Improvement

DEMO DATA

Move from audit findings to measurable improvement — baseline summary, aim, PDSA cycles, interventions, sustainability and re-audit planning.

Governance reminder
Lazomis QI supports quality improvement planning and documentation. It does not replace clinical judgement, local antimicrobial policy, microbiology / ID advice, critical care advice, pharmacy advice, professional responsibility or organisational governance processes.
1. Baseline findings summary
Pulled from dashboard where possible.
2. Key problems identified
3. Root cause / contributory factors
People · Process · Environment · IT · Documentation · Communication · Training · Workload
4. Improvement aim
Specific, measurable, achievable, relevant, time-bound
5. Suggested local improvement actions
Editable — framed as local implementation ideas, not national guidance.
ActionLinked problemOwnerTargetStatus
EPR time-critical review task triggered by IV targeted / 3 alertDelayed clinical review for stage 2 antibiotic reviewIT & antibiotic review Committee8 weeks
Planned
Ward-based pharmacy screening of antimicrobial / renally cleared medicines on antibiotic review admissionsRegimen review (culture / sensitivity) not documentedLead Renal Pharmacist6 weeks
In progress
Structured senior review checklist for stage 2 / 3 antibiotic reviewVariable senior inputClinical Director12 weeks
Planned
Standardised antibiotic review discharge bundle with antibiotic response follow-up planDischarge antimicrobial plan plan missingQI Lead10 weeks
Not started
6. PDSA cycle 1
Plan · Do · Study · Act
7. Intervention log
8. Re-audit plan
9. Sustainability plan
10. Learning points
11. Governance summary
12. ARCP / portfolio evidence summary
Populates the ARCP evidence output.
Improvement themes
Common action areas for antibiotic review at 48–72 hours.
antibiotic review and EPR alert response
Timeliness of clinical review by Antibiotic route
Senior review for stage 2 and 3 antibiotic review
Allergy status and fluid management
Duration / stop date monitoring
Cultures before first dose and obstruction assessment
Microbiology results review pathway
Regimen review (culture / sensitivity) and nephrotoxin stewardship
Renal dosing and dose appropriate for renal / hepatic function
Empirical guideline concordance management
Sepsis and antibiotic review co-management
OPAT / micro referral pathway
Critical care / outreach escalation
antibiotic review discharge bundle and follow-up
Patient advice and antibiotic course information
Pharmacy-led regimen review (culture / sensitivity)
Weekend / out-of-hours pathway
Ward-level feedback and sustainability